| scholarly article | Q13442814 |
| P2093 | author name string | Yong Zhang | |
| Xiaoming Li | |||
| Dengbin Wang | |||
| Huanhuan Liu | |||
| Caiyuan Zhang | |||
| Tianyong Xu | |||
| Yanfen Cui | |||
| Bing Yin | |||
| P2860 | cites work | Prediction of treatment response in head and neck carcinomas using IVIM-DWI: Evaluation of lymph node metastasis. | Q51101820 |
| Tumor perfusion-related parameter of diffusion-weighted magnetic resonance imaging: correlation with histological microvessel density. | Q51195343 | ||
| Intravoxel incoherent motion MRI for the differentiation between mass forming chronic pancreatitis and pancreatic carcinoma | Q51626999 | ||
| The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study | Q51673775 | ||
| Intravoxel incoherent motion diffusion-weighted MR imaging for monitoring the therapeutic efficacy of the vascular disrupting agent CKD-516 in rabbit VX2 liver tumors | Q52649093 | ||
| Investigation of renal lesions by diffusion-weighted magnetic resonance imaging applying intravoxel incoherent motion-derived parameters—Initial experience | Q82612719 | ||
| Initial experience of correlating parameters of intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging at 3.0 T in nasopharyngeal carcinoma | Q87425954 | ||
| Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging | Q22065375 | ||
| AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging | Q28293708 | ||
| Diffusion-weighted MRI in the body: applications and challenges in oncology | Q31113294 | ||
| Effects of AZD2171 and vandetanib (ZD6474, Zactima) on haemodynamic variables in an SW620 human colon tumour model: an investigation using dynamic contrast-enhanced MRI and the rapid clearance blood pool contrast agent, P792 (gadomelitol). | Q33282771 | ||
| Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival | Q33515519 | ||
| Intravoxel incoherent motion MRI: emerging applications for nasopharyngeal carcinoma at the primary site | Q33848934 | ||
| Liver fibrosis: An intravoxel incoherent motion (IVIM) study | Q34159097 | ||
| Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. | Q34193619 | ||
| Magnetic resonance imaging identifies early effects of sunitinib treatment in human melanoma xenografts | Q34249349 | ||
| The capillary network: a link between IVIM and classical perfusion | Q34261100 | ||
| Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model. | Q34810321 | ||
| Metastasis and angiogenesis. | Q35688573 | ||
| Antiangiogenic therapy for cancer: current and emerging concepts | Q36149950 | ||
| Intravoxel incoherent motion diffusion-weighted MRI at 3.0 T differentiates malignant breast lesions from benign lesions and breast parenchyma | Q36672737 | ||
| Vandetanib (ZD6474): an orally available receptor tyrosine kinase inhibitor that selectively targets pathways critical for tumor growth and angiogenesis | Q36715777 | ||
| Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy | Q37042355 | ||
| Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma | Q37177871 | ||
| Non-Gaussian analysis of diffusion weighted imaging in head and neck at 3T: a pilot study in patients with nasopharyngeal carcinoma. | Q37510711 | ||
| Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy | Q37762058 | ||
| New advances in molecular approaches to head and neck squamous cell carcinoma | Q37823161 | ||
| Tumor angiogenesis: molecular pathways and therapeutic targets | Q37953773 | ||
| Antitumor activity of enzastaurin as radiation sensitizer in head and neck squamous cell carcinoma. | Q39641088 | ||
| The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells. | Q39644790 | ||
| Induction of cell cycle arrest and apoptosis in human nasopharyngeal carcinoma cells by ZD6474, an inhibitor of VEGFR tyrosine kinase with additional activity against EGFR tyrosine kinase. | Q40107033 | ||
| Detection of early antiangiogenic effects in human colon adenocarcinoma xenografts: in vivo changes of tumor blood volume in response to experimental VEGFR tyrosine kinase inhibitor | Q40360975 | ||
| Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. | Q40657525 | ||
| Intravoxel incoherent motion diffusion-weighted imaging in head and neck squamous cell carcinoma: assessment of perfusion-related parameters compared to dynamic contrast-enhanced MRI. | Q43521240 | ||
| Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer a | Q44601128 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diffusion-weighted magnetic resonance imaging | Q899360 |
| P304 | page(s) | 16389 | |
| P577 | publication date | 2015-11-17 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging for Monitoring the Early Response to ZD6474 from Nasopharyngeal Carcinoma in Nude Mouse | |
| P478 | volume | 5 |
| Q26745449 | Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma |
| Q59812887 | Designing multifunctional cancer-targeted nanosystem for magnetic resonance molecular imaging-guided theranostics of lung cancer |
| Q33600778 | Early Changes in Glutamate Metabolism and Perfusion in Basal Ganglia following Hypoxia-Ischemia in Neonatal Piglets: A Multi-Sequence 3.0T MR Study |
| Q48103389 | Intravoxel incoherent motion MRI as a means to measure in vivo perfusion: A review of the evidence |
| Q58779843 | Intravoxel incoherent motion MRI in neurological and cerebrovascular diseases |
| Q64913771 | Longitudinal Assessment of Intravoxel Incoherent Motion Diffusion Weighted Imaging in Evaluating the Radio-sensitivity of Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiation Therapy. |
| Q91781644 | Monitoring the Early Antiproliferative Effect of the Analgesic-Antitumor Peptide, BmK AGAP on Breast Cancer Using Intravoxel Incoherent Motion With a Reduced Distribution of Four b-Values |
| Q49475238 | Preclinical Imaging for the Study of Mouse Models of Thyroid Cancer |
| Q92627379 | Radiomic Nomogram: Pretreatment Evaluation of Local Recurrence in Nasopharyngeal Carcinoma based on MR Imaging |
Search more.